Deck

Yadea Group Holdings · 1585 · HKEX

Yadea makes 16 million electric scooters and mopeds a year — the world's largest two-wheeler maker by units — selling through a 40,000-outlet Chinese dealer network with batteries built in-house at subsidiary Huayu.

$1.44
Price
$4.4B
Market cap
$5.29B
Revenue (FY2025)
16.3M
Units sold (FY2025)
Listed HKEX May 2016 at $0.17; ran 17× to $2.89 in Jan-2021 on the post-2019 scrappage cycle; back to $1.44 — halfway to IPO, sitting in the bottom 14% of its 52-week range. Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
2 · The tension

Strip the cash and the operating business trades at ~3.4× EBITDA — but the cash flow that builds the pile is bank-mediated.

  • The valuation gap. Net cash of $2.47B equals 58% of the $4.4B market cap. Strip it and the operating company sits at ~3.4× EV/EBITDA versus AIMA at 7.8× and Ninebot at 12.7×. Closing the gap to AIMA's multiple would imply roughly $2.49/share — the size of the discount, not a forecast.
  • The inflection that started the story. FY2025 declared distributions hit $0.097/share (final $0.068 plus a $0.029 special) — +245% YoY. Capex collapsed from $206M to $108M, payout ratio ran to ~50%, ROE printed 27.8% with no reinvestment runway left.
  • The catch. Reported CFO swung from $41M to $856M — but $329M came from a bills-payable build and a brand-new $211M supplier-finance program that discounts dealer bills through banks. Strip both and CFO/NI falls from 2.06× to 1.13×.
The cash mountain is real. The cash flow that fed it last year may not be.
3 · Money picture

FY2025 was the cleanest cycle peak in a decade — and it sits on top of a $2.5B war chest.

+31%
Revenue YoY $5.29B FY2025
+129%
Net income YoY $416M FY2025
27.8%
Return on equity FY2024 trough 14.5%
$2.47B
Net cash 58% of market cap

A 31% revenue jump produced a 129% earnings jump because roughly 70% of the cost base is fixed — the same operating leverage that took FY2024 net income down 52% on a 19% revenue dip. Gross margin hit 19.1%, the top of a 10-year range, helped by the post-Nanjing lithium rule pulling demand into premium-mix scooters and the NDRC trade-in subsidy. The 6-year average net income is $270M; FY2025 is the upper rail, not the run-rate.

4 · The forensic file

Three signals fire at once — auditor swap, supplier-finance program, and a cash-flow line that doubles on working capital.

  • PwC out in 56 days. Reappointed at the 17-Jun-2025 AGM, resigned 12-Aug-2025; Deloitte slotted 22-Sep-2025 and signed a clean opinion 30-Mar-2026. Second Big-Four exit in five years — Deloitte itself walked in 2020 over a fee dispute. Audit fee then fell 11% YoY against a 22% balance-sheet expansion.
  • New supplier-finance program. Note 29 discloses $211M of bills discounted through banks in FY2025 (zero in FY2024), $154M outstanding. Bills payable now $1.41B — 70% of total payables. The settlement runs through operating cash; the financing piece sits in the footnote.
  • Other income carrying real weight. $101M of 'other income and gains' = 19.5% of operating profit — $33M government grants, $25M VAT super-deduction, $26M fair-value gains on wealth-management products. Strip them and operating margin falls from 9.83% to ~7.9%.
Income statement is broadly defensible. The cash-flow statement is doing more presentational work than the 2.06× CFO/NI headline suggests.
5 · The competitive question

Yadea is the global volume leader — but AIMA out-earned it on net margin in the FY2024 trough.

  • Scale is the moat. 16.3M units in FY2025 — global #1 in E2W by volume, ~1.4× AIMA and roughly a third of China's ~49.5M-unit annual market. 5,122 distributors and 40,000+ retail outlets across China, a footprint that would take a decade and tens of billions to replicate. Plus 10 overseas plants — more than any listed peer.
  • AIMA matches it on profitability. AIMA earned 9.2% net margin in FY2024 versus Yadea's 4.5% — the closest comparator out-earned Yadea per yuan of revenue in the year that stress-tested the moat. The premium-tech crowd (Niu, Ola, Gogoro) all lose money at sub-scale. This is a duopoly moat, not a monopoly moat.
  • Regulation does the consolidation work. MIIT's 2024 Standard Conditions rule (R&D ≥2%, mandatory lithium cert post-Nanjing fire) is forcing ~80 small OEMs out. Yadea spends 3.8% on R&D; top-5 share is moving from ~50% toward 60%+ — a tailwind shared with AIMA, not exclusive to Yadea.
6 · The setup

Tape is bearish into the one print that can resolve the debate.

  • Bottom 14% of the 52-week range. $1.44 sits 8.6% below the 200-day SMA after a third 50/200 death cross in 2025 (13-Nov). YTD −2.3%, 1-year −14.2%; volume fading on the downtrend rather than capitulating. Consensus PT $2.23.
  • Short book rebuilt to a 7-month high. SFC reportable shorts at 140.4M shares ($211M) — ~4.5% of shares out, ~22 days to cover. The +25.7% rebuild from the Oct-2025 trough tracks the auditor swap, the death cross, and the forensic file move-for-move.
  • H1 2026 interim is the single dated catalyst. Board meeting expected ~26-Aug-2026. H1 2025 comp was strong — revenue +33%, gross margin 19.6%, net profit +59%. A clean beat with bills payable contracting and GM holding ≥17% would refute the bear case; a soft print would confirm it.
7 · Bull & Bear

Lean long, wait for confirmation — the cash math is too sharp to dismiss, the auditor file too live to size up.

  • For. 58% of market cap in net cash; operating core at 3.4× EBITDA versus AIMA 7.8×. Closing that gap to AIMA's multiple alone would imply ~$2.49.
  • For. The FY2025 +245% YoY dividend with a special, on collapsed capex and 27.8% ROE, suggests the cash is starting to come out. The FY26 declaration tells you whether it was a regime change or a sweetener.
  • Against. Strip the $211M supplier-finance discounting and the $329M bills-payable build and CFO/NI falls from 2.06× to 1.13×. The 'cash compounder' leg collapses into a working-capital release that does not repeat.
  • Against. Two Big-Four exits in five years, PwC resigning 56 days after reappointment, ISS Governance QualityScore 9/10 (worst decile), and SFC shorts up 25.7% in seven months under the same thesis.
My view — the valuation gap is institutionally attractive, but the H1 2026 interim print (Aug 2026) on bills-payable and gross margin has to clear before sizing up.

Watchlist to re-rate: 1) FY2026 capital-return cadence — a second special dividend or structural buyback authorization ≥$429M confirms the regime. 2) H1 2026 bills-payable balance (contracting = bull; above $1.57B = bear). 3) Deloitte's FY2026 opinion in Mar-2027 — any expanded Key Audit Matter on revenue cut-off or payables classification breaks the thesis.